A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Clinical trial NCT04445220 · UNKNOWN
Trial details
- NCT number
- NCT04445220
- Sponsor
- Sentien Biotechnologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2022-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.